Gerard Burger

Chief Executive Officer at Laboratoires Majorelle SAS

66 year

Distribution Services

Health Technology

Profile

Gerard Burger has held positions in Laboratoires Majorelle SAS and Scomedica SASU.
Currently, he holds the position of Co-Chief Executive Officer at Laboratoires Majorelle SAS and Chairman at Scomedica SASU.

Gerard Burger active positions

Companies	Position	Start
Laboratoires Majorelle SAS Laboratoires Majorelle SAS Medical DistributorsDistribution Services Laboratoires Majorelle SAS operates as an independent French pharmaceutical company. Its products include Vitaros, Optilov, Keat range, and Carmex. The company was founded by Guillaume El Glaoui in 2012 and is headquartered in Paris, France.	Chief Executive Officer	27/10/2020
Scomedica SASU Scomedica SASU Pharmaceuticals: MajorHealth Technology Part of Seelos Therapeutics, Inc., Scomedica SASU is a pharmaceutical company based in Montigny-le-Bretonneux, France. The French company manufactures pharmaceutical products. Scomedica was acquired by Apricus Biosciences, Inc. from Finesco, Inc. on July 13, 2012 for $11.16 million.	Chairman	-

All active positions of Gerard Burger

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Gerard Burger's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Laboratoires Majorelle SAS Laboratoires Majorelle SAS Medical DistributorsDistribution Services Laboratoires Majorelle SAS operates as an independent French pharmaceutical company. Its products include Vitaros, Optilov, Keat range, and Carmex. The company was founded by Guillaume El Glaoui in 2012 and is headquartered in Paris, France.	Distribution Services
Scomedica SASU Scomedica SASU Pharmaceuticals: MajorHealth Technology Part of Seelos Therapeutics, Inc., Scomedica SASU is a pharmaceutical company based in Montigny-le-Bretonneux, France. The French company manufactures pharmaceutical products. Scomedica was acquired by Apricus Biosciences, Inc. from Finesco, Inc. on July 13, 2012 for $11.16 million.	Health Technology

See company connections

Stock Market
Insiders
Gerard Burger